Market Research Logo

Canadian Market Report for Orthopedic Hyaluronic Acid 2016 - MedCore

Canadian Market Report for Orthopedic Hyaluronic Acid 2016 - MedCore

Hyaluronic acid viscosupplementation (HA) as a treatment for osteoarthritis has been available in Canada since the late 90’s with the major international brands receiving regulatory approval from Health Canada in 1999 and 2000. Unlike many other HA markets around the world, Canada has never seen the five-injection market reaching scale, instead the three-injection market served as the first mainstream product for the HA treatment until 2003 when the first single-injection product became available. The three-injection market slowed and subsequently started to decline when other established brands also started marketing single-injection solutions in 2009. As of 2015 the market split between single and three-injection products continues to trend towards single-injection, albeit at a slower pace; single-injection market is currently occupying 57.5% of the total market with the three-injection market accounting for the balance, slightly up from 2012 when single-injection market accounted for 55% share. No device was strictly indicated as a five-injection course only; two brands (Hyalgan® and Ostenil®) are sold as individually packaged syringes and an immaterial number of their units were found to be used as five-injection solutions. For the purpose of this report, all estimated units for these two brands were accounted for under the three-injection category.

One of the market limiters for the Canadian HA market is the reimbursement structure. None of the products are covered under standard healthcare plans and must be purchased directly or through extended healthcare coverage or private insurance. Thus, some patients opt out to receiving cortisone injections; these are reimbursed by standard healthcare and are a more affordable choice.

One of the factors that contributed positively to this market is ever expanding indication. The market originally started with treating osteoarthritis (OA) of the knee, since then some products expanded into hip, shoulder, a number of small joints, as well as assisting with post-surgery joint recovery.


EXECUTIVE SUMMARY
CANADIAN ORTHOPEDIC BIOMATERIALS MARKET
TOP CANADIAN ORTHOPEDIC BIOMATERIALS COMPANIES
MARKET DEVELOPMENTS
RESEARCH METHODOLOGY
2.1 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
2.2 RESEARCH SCOPE
ORTHOPEDIC HYALURONIC ACID MARKET
3.1 MARKET OVERVIEW
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Single-Injection HA Market
3.2.2 Three-Injection HA Market
3.2.3 Five-Injection HA Market
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 3 1: Orthopedic Hyaluronic Acid Market by Segment, Canada, 2012 – 2022
Chart 3 2: Orthopedic Hyaluronic Acid Market Breakdown, Canada, 2015
Chart 3 3: Orthopedic Hyaluronic Acid Market Breakdown, Canada, 2022
Chart 3 4: Single-Injection HA Market, Canada, 2012 – 2022
Chart 3 5: Three-Injection HA Market, Canada, 2012 – 2022
Chart 3 6: Leading Competitors, Orthopedic Hyaluronic Acid Market, Canada, 2015
List of Figures
Figure 1 1: Orthopedic Biomaterials Competitor Market Share Ranking by Segment, Canada, 2015
Figure 1 2: Recent Events in the Orthopedic Biomaterials Market, Canada, 2012 – 2015
Figure 3 1: Orthopedic Hyaluronic Market by Segment, Canada, 2012 – 2022 (US$M)
Figure 3 2: Orthopedic Hyaluronic Market by Segment, Canada, 2012 – 2022 (CAD$M)
Figure 3 3: Statistics Canada National Estimates on Osteoarthritis Patients in Canada, 2009
Figure 3 4: CMA National Census on Active Orthopedic Physicians, 2015
Figure 3 5: Single-Injection HA Market, Canada, 2012 – 2022 (US$ and CAD$)
Figure 3 6: Three-Injection HA Market, Canada, 2012 – 2022 (US$ and CAD$)
Figure 3 7: Leading Competitors, Orthopedic Hyaluronic Acid Market, Canada, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report